Literature DB >> 23297421

Regulation of GTP-binding protein (Gαs) expression in human myometrial cells: a role for tumor necrosis factor in modulating Gαs promoter acetylation by transcriptional complexes.

Steve J Webster1, Sarah L Waite, Victoria J Cookson, Averil Warren, Raheela Khan, Saurabh V Gandhi, G Nicholas Europe-Finner, Neil R Chapman.   

Abstract

The onset of parturition is associated with a number of proinflammatory mediators that are themselves regulated by the nuclear factor κB (NF-κB) family of transcription factors. In this context, we previously reported that the RelA NF-κB subunit represses transcription and mRNA expression of the proquiescent Gαs gene in human myometrial cells following stimulation with the proinflammatory cytokine TNF. In the present study, we initially defined the functional consequence of this on myometrial contractility. Here we show that, contrary to our initial expectations, TNF did not induce myometrial contractility but did inhibit the relaxation produced by the histone deacetylase inhibitor trichostatin A, an effect that in turn was abolished by the NF-κB inhibitor N(4)-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine. This result suggested a role for TNF in regulating Gαs expression via activating NF-κB and modifying histone acetylation associated with the promoter region of the gene. In this context, we show that the -837 to -618 region of the endogenous Gαs promoter is occupied by cAMP-response element-binding protein (CREB), Egr-1, and Sp1 transcription factors and that CREB-binding protein (CBP) transcriptional complexes form within this region where they induce histone acetylation, resulting in increased Gαs expression. TNF, acting via NF-κB, did not change the levels of CREB, Sp1, or Egr-1 binding to the Gαs promoter, but it induced a significant reduction in the level of CBP. This was associated with increased levels of histone deacetylase-1 and surprisingly an increase in H4K8 acetylation. The latter is discussed herein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23297421      PMCID: PMC3585108          DOI: 10.1074/jbc.M112.440602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases.

Authors:  Robert J Phillips; Alison J Tyson-Capper Née Pollard; Jarrod Bailey; Stephen C Robson; G Nicholas Europe-Finner
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

3.  Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.

Authors:  Yun Dai; Mohamed Rahmani; Paul Dent; Steven Grant
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour.

Authors:  J Bailey; C Sparey; R J Phillips; K Gilmore; S C Robson; W Dunlop; G N Europe-Finner
Journal:  Mol Hum Reprod       Date:  2000-07       Impact factor: 4.025

5.  Expression of the GTP-binding protein (Galphas) is repressed by the nuclear factor kappaB RelA subunit in human myometrium.

Authors:  Neil R Chapman; Ioannis Smyrnias; Dilly O C Anumba; G Nicholas Europe-Finner; Stephen C Robson
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

6.  Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1.

Authors:  N R Chapman; N D Perkins
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

7.  Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'.

Authors:  V C Allport; D Pieber; D M Slater; R Newton; J O White; P R Bennett
Journal:  Mol Hum Reprod       Date:  2001-06       Impact factor: 4.025

8.  Regulation of chromatin structure by site-specific histone H3 methyltransferases.

Authors:  S Rea; F Eisenhaber; D O'Carroll; B D Strahl; Z W Sun; M Schmid; S Opravil; K Mechtler; C P Ponting; C D Allis; T Jenuwein
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

9.  Expression and interaction of the transcriptional coregulators, CBP/p300, in the human myometrium during pregnancy and labor.

Authors:  Audrey A Long; Neil R Chapman; Barbara Innes; G Nicholas Europe-Finner; Stephen C Robson
Journal:  J Soc Gynecol Investig       Date:  2005-02

10.  15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications.

Authors:  Tamsin M Lindström; Phillip R Bennett
Journal:  J Clin Endocrinol Metab       Date:  2005-03-08       Impact factor: 5.958

View more
  3 in total

Review 1.  Transcription factors regulated by cAMP in smooth muscle of the myometrium at human parturition.

Authors:  Jonathan K H Li; Pei F Lai; Rachel M Tribe; Mark R Johnson
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

2.  Inhibition of Inflammatory Changes in Human Myometrial Cells by Cell Penetrating Peptide and Small Molecule Inhibitors of NFκB.

Authors:  Leo R I Gurney; Julie Taggart; Wing-Chiu Tong; Arwyn T Jones; Stephen C Robson; Michael J Taggart
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

3.  The effect of trichostatin-A and tumor necrosis factor on expression of splice variants of the MaxiK and L-type channels in human myometrium.

Authors:  Sarah L Waite; Saurabh V Gandhi; Raheela N Khan; Neil R Chapman
Journal:  Front Physiol       Date:  2014-07-15       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.